DAFTAR PUSTAKA

1. Fitzpatrick's dermatology in general medicine. 8th ed. New York: Mc Graw

Hill Medical; 2012.

2. James WD, Berger TG, Eiston DM. Andrews diseases of the skin clinical
dermatology. 11th ed.: Saunders Elsevier; 2011.

3. Sperling L. Hair and systemic disease: Dermatologic Clinic; 2001.

4. Hutapea S, Rosita C. Telogen Efluvium. Berkala Ilmu Kesehatan Kulit

Kelamin. 2011 April; 23.

5. Ivanivna FM, Petrivna ON, Mykolaivna FS. Study of vasodilating and

regenerative effect of the gel with nettle juice intended for telogen effluvium
treatment. Jornal of Applied Pharmaceutical Science. 2018 January; 8.

6. Malkud S. Telogen effluvium: a review. Journal of Clinical and Diagnostic

Research. 2015 September; 9.

7. GR T, CR K, EK V. Examination of fluconazole-induced alopecia in an animal

model and human cohort. Antimcrobial agent and chemotheraphy. 2019
February; 2.

8. A A, F K, S S. Research on the balance of thiol-fisulfide in blood serum in

women with telogen effluvium. International Journal of Trichology. 2016.

9. T D, K D. Telogen effluvium with dysesthesia (TED) has lower b12 levels and
may respond to b12 supplementation. Journal of drugs dermatology. 2018
January; 11.

10. PM R, E F, C M, M S. HrQoL in hair loss-affected patients with alopecia

areata, androgenetic alopecia and telogen effluvium: the role of personality
traits and psychosocial anxiety. Jornal of the European Academy of
Dermatology and Venerology. 2019 Maret ; 3.